New white paper series presents recent findings and information on the use of proton therapy in oncology

On the occasion of ASTRO 2015, IBA publishes the first two installments in its white paper series on proton therapy in oncology. The series offers a compilation of information on current practice, opportunities and challenges of proton therapy in oncology. In addition to providing a general introduction to proton therapy, the white papers will present an overview of indication-specific data and findings, with the primary purpose of facilitating access to the most relevant information on the use of proton therapy for stakeholders in radiation oncology worldwide.

“Even though the clinical application of proton therapy is a medical field in full evolution, we have worked to ensure that these white papers are as complete, correct and up-to-date as possible. Our hope is that this information will deepen and advance radiotherapy and oncology experts’ understanding of proton therapy cancer treatment, so that we can continue to make proton therapy accessible to more patients worldwide,” says Michel Closset, IBA’s Clinical Director.